Cambridge Investment Research Advisors’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDR
HPC
SVWAG
Cambridge Investment Research Advisors's IBDR Position: Q1 2026 in Review
Cambridge Investment Research Advisors reduced its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 2.9% in Q1 2026, selling an estimated $160K and leaving 222,894 shares worth $5.4M. The position accounts for 0.01% of the portfolio, ranked #923.
Cambridge Investment Research Advisors first reported a position in IBDR in Q1 2019 and has held it in 25 quarters since. The position peaked at $5.83M in Q3 2025. 439 funds tracked by Wall St. Rank hold IBDR as of Q1 2026.
- Cambridge Investment Research Advisors held 222,894 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $5.4M as of Q1 2026.
- Cambridge Investment Research Advisors sold 6,607 iShares iBonds Dec 2026 Term Corporate ETF shares in Q1 2026, an estimated $160K.
- iShares iBonds Dec 2026 Term Corporate ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #923 holding.
- Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q1 2019 and has held it in 25 quarters since.
- Cambridge Investment Research Advisors's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $5.83M in Q3 2025.
- 439 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q1 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.